title: Liposomal amphotericin B (Ambisome) is safe and effective in the treatment of invasive mycosis in organ transplant patients.
authors.affiliation: Department of Surgery B, Tel Aviv Medical Center, Israel.
authors.forename: H
authors.initials: H
authors.lastname: Merhav
authors.forename: R
authors.initials: R
authors.lastname: Nakache
authors.forename: I
authors.initials: I
authors.lastname: Houri
authors.forename: R
authors.initials: R
authors.lastname: Orni-Wasserlauf
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D006801:Humans; D009181:Mycoses / Q000145:classification / Q000188:drug therapy*; D016377:Organ Transplantation; D011183:Postoperative Complications / Q000188:drug therapy; D015203:Reproducibility of Results; D012189:Retrospective Studies; D012449:Safety
chemical_list: D000935:Antifungal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B